Medicare Enrolled
Dr. Richard Berquist, MD
Family Medicine · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berquist from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berquist?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berquist
Dr. Richard Berquist is a family medicine specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berquist performed 1,488 Medicare services across 840 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berquist received a total of $14,945 from 63 pharmaceutical and/or device companies across 593 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berquist is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in CA
$14,945 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,488
Medicare services
Top 15% in CA for family medicine
840
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~74 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
737 | $88 | $405 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $54 | $285 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
130 | $11 | $69 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
91 | $32 | $69 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
89 | $72 | $183 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
47 | $90 | $405 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
34 | $135 | $413 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
31 | $41 | $230 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
20 | $3 | $16 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $32 | $45 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
15 | $29 | $148 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
15 | $282 | $794 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
15 | $153 | $645 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
15 | $172 | $523 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,945
Total received (2018-2024)
Avg $2,135/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
593
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,961 (86.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,984 (13.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,004
2023
$1,638
2022
$2,858
2021
$1,938
2020
$995
2019
$1,140
2018
$4,371
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$382
AstraZeneca Pharmaceuticals LP
$237
Esperion Therapeutics, Inc.
$180
PFIZER INC.
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$164
Amgen Inc.
$153
Bayer Healthcare Pharmaceuticals Inc.
$137
Otsuka America Pharmaceutical, Inc.
$84
Lilly USA, LLC
$82
Exact Sciences Corporation
$69
Hologic Sales and Service, LLC
$68
Lundbeck LLC
$42
Astellas Pharma US Inc
$40
Novo Nordisk Inc
$36
GlaxoSmithKline, LLC.
$34
Xeris Pharmaceuticals, Inc.
$25
Daiichi Sankyo Inc.
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Dynavax Technologies Corporation
$21
Phathom Pharmaceuticals, Inc.
$19
AIMMUNE THERAPEUTICS, INC.
$13
Top 3 companies account for 39.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,232
Ironwood Pharmaceuticals, Inc
$1,964
AstraZeneca Pharmaceuticals LP
$1,408
Lilly USA, LLC
$817
AbbVie Inc.
$715
Boehringer Ingelheim Pharmaceuticals, Inc.
$613
Kowa Pharmaceuticals America, Inc.
$551
Merck Sharp & Dohme Corporation
$526
Amgen Inc.
$495
GlaxoSmithKline, LLC.
$448
Astellas Pharma US Inc
$437
Janssen Pharmaceuticals, Inc
$383
Otsuka America Pharmaceutical, Inc.
$331
Novo Nordisk Inc
$302
PFIZER INC.
$260
Bayer Healthcare Pharmaceuticals Inc.
$219
Esperion Therapeutics, Inc.
$215
Abbott Laboratories
$209
Regeneron Healthcare Solutions, Inc.
$190
Biohaven Pharmaceuticals, Inc.
$187
Novartis Pharmaceuticals Corporation
$186
Corcept Therapeutics
$184
Allergan, Inc.
$163
Teva Pharmaceuticals USA, Inc.
$130
Takeda Pharmaceuticals U.S.A., Inc.
$111
Bayer HealthCare Pharmaceuticals Inc.
$111
JAZZ PHARMACEUTICALS INC.
$111
Eisai Inc.
$106
AbbVie, Inc.
$103
Gilead Sciences, Inc.
$89
Dynavax Technologies Corporation
$79
Lundbeck LLC
$78
Nevro Corp.
$76
Biohaven Pharmaceutical Holding Company Ltd.
$74
Exact Sciences Corporation
$69
Hologic Sales and Service, LLC
$68
Philips Electronics North America Corporation
$57
Daiichi Sankyo Inc.
$48
SANOFI PASTEUR INC.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
Allergan Inc.
$36
SANOFI-AVENTIS U.S. LLC
$36
Jazz Pharmaceuticals Inc.
$30
Amarin Pharma Inc.
$30
Cardiovascular Systems Inc.
$29
Xeris Pharmaceuticals, Inc.
$25
Almatica Pharma LLC
$25
Shire North American Group Inc
$24
EISAI INC.
$23
Dexcom, Inc.
$23
Sanofi Pasteur Inc.
$23
GENZYME CORPORATION
$23
Axsome Therapeutics, Inc.
$22
Mylan Specialty L.P.
$21
Inspire Medical Systems, Inc.
$21
Phathom Pharmaceuticals, Inc.
$19
Seqirus USA Inc
$18
Ironshore Pharmaceuticals Inc.
$18
Hologic, LLC
$15
AIMMUNE THERAPEUTICS, INC.
$13
Bioventus LLC
$13
MannKind Corporation
$13
Shionogi Inc
$12
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · ANORO · ANORO ELLIPTA · Aimovig · Auvelity · BELSOMRA · BEXSERO · BREZTRI · BYDUREON · Belviq · CREON · Cologuard Collection Kit · Creon · DUPIXENT · DUZALLO · Dayvigo · Dexcom G6 Transmitter · Durolane · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · Fluad · GRALISE · GVOKE HYPOPEN · HUMALOG · Health&WellnessUndiv · Heplisav-B · INJECTAFER · INSPIRE · JANUVIA · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · Korlym · LINZESS · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NATPARA · NEXLETOL · NEXLIZET · NUCALA · NURTEC ODT · OFEV · Omnia · Otezla · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Peripheral Orbital Atherectomy System · QUADRACEL · QULIPTA · QVAR · REXULTI · RYBELSUS · Repatha · Respiratoriy Care Undiv · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Symproic · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thinprep · Tresiba · Trintellix · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN · XYREM · XYWAV · Xyrem · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
359
Per 100K population
35.5
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berquist is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berquist experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Berquist performed 737 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berquist receive payments from pharmaceutical companies?
Yes. Dr. Berquist received a total of $14,945 from 63 companies across 593 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berquist's costs compare to other family medicine physicians in Fresno?
Dr. Berquist's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berquist) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Fresno
Browse family medicine physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Ironwood Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ironwood Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology